Deals & Cases
Barclays Private Equity acquires fine chemical specialist CU UETIKON
Lenz & Staehelin assisted Barclays Private Equity ("BPE") acquiring a majority shareholding of the fine chemical specialist CU Chemie UETIKON GmbH ("CU UETIKON") based in Lahr, Germany. CU UETIKON is an established manufacturer of fine chemicals and active pharmaceutical ingredients and has been operating from its site in Lahr in the German Black Forest for over 40 years. With a shareholding of 90 percent, BPE will have a controlling interest in the spin-off from the Swiss group CPH Chemie + Papier Holding AG. Together with management, BPE will pursue a consistent growth strategy in pharmaceuticals, cosmetics and nutrition industries. The consideration is undisclosed and completion is subject to regulatory approval.
The Lenz & Staehelin team consisted of Andreas Rötheli, Hans-Jakob Diem and Anil Nair (all Corporate and M&A).